GHK-Cu
100 mg / 3 ml · Injectable pen
Copper peptide · pen presentation
GHK-Cu in the HAVO pen presentation, with 100 mg total content in 3 ml. Read the available safety context for injectable preparations.
Overview
The supplied HAVO packaging identifies GHK-Cu 100 mg / 3 ml for subcutaneous administration. This presentation should not be equated with a topical cosmetic.
Mechanism & scientific context
GHK-Cu is a copper-associated peptide. Experimental or topical findings do not establish clinical benefits for this injectable HAVO presentation.
Indications & evidence
No approved therapeutic indication for this HAVO injectable is established by the documentation available here.
Presentation & box contents
Pen presentation with a declared volume of 3 ml. The amount shown is the total content, not a dose per injection. Needle compatibility, dose settings and included accessories must be checked against the instructions supplied with the product.
Contraindications
A validated manufacturer contraindication list is unavailable. This does not mean there are no contraindications.
Precautions
The FDA highlights limited human safety data and potential immunogenicity associated with aggregation and peptide impurities in injectable GHK-Cu. A clinician must assess the complete formulation and available evidence.
Storage & handling
Keep refrigerated between 2°C and 8°C, as specified by HAVO for this presentation. Follow the product label for expiry and the period after first use. No room-temperature allowance or in-use shelf life has been established here. If frozen, damaged or exposed to temperatures outside this range, contact the laboratory before use.
Scientific information about an ingredient does not establish approval, efficacy or equivalence of this HAVO presentation. Consult the local product documentation and a qualified healthcare professional. This summary is not a prescribing guide.